22:50 , May 11, 2018 |  BioCentury  |  Finance

Watching the wave

After raising the largest ever series B round for a Chinese biotech, CStone Pharmaceuticals Co. Ltd. should have enough funding to run four pivotal cancer studies in parallel as it monitors the performance of the...
18:12 , May 11, 2018 |  BC Week In Review  |  Financial News

Chinese immuno-oncology play CStone raises $260M

CStone Pharmaceuticals Co. Ltd. (Suzhou, China) raised on May 8 $260 million in a series B round led by new investor GIC Private. CStone said the round is the largest series B ever for a...
16:38 , May 9, 2018 |  BC Extra  |  Financial News

Chinese immuno-oncology play CStone raises $260M

CStone Pharmaceuticals Co. Ltd. (Suzhou, China) raised $260 million in a series B round led by new investor GIC Private. CStone said the round is the largest series B ever for a Chinese biopharma. New...
16:17 , Sep 8, 2017 |  BC Week In Review  |  Financial News

WuXi NextCode closes $240M series B round

Genomics company WuXi NextCode Genomics Inc. (Cambridge, Mass.) raised an additional $165 million on Sept. 7 in an extension led by Sequoia China to complete a $240 million series B round. Temasek, Yunfeng Capital and...
19:15 , Sep 7, 2017 |  BC Extra  |  Financial News

WuXi NextCode closes $240M series B round

WuXi NextCode Genomics Inc. (Cambridge, Mass.) raised an additional $165 million in an extension led by Sequoia China to complete a $240 million series B round. Temasek, Yunfeng Capital and 3W Partners also participated. In...
21:41 , Jun 16, 2017 |  BioCentury  |  Finance

Twist's proof points

Twist Bioscience Corp. is expanding its drug discovery and data storage businesses and ramping up its core DNA synthesis business to build a stronger case for an IPO. When Twist raised a $61 million series...
05:20 , Jun 16, 2017 |  BC Week In Review  |  Financial News

Twist tops off $60M round

On June 14, synthetic DNA company Twist Bioscience Corp. (San Francisco, Calif.) raised $27 million in the second close of an undisclosed venture round, bringing the round’s total to $60 million. Investors included Biomatics Capital,...
20:39 , Jun 14, 2017 |  BC Extra  |  Financial News

Twist tops off $60 million round

Synthetic DNA company Twist Bioscience Corp. (San Francisco, Calif.) raised $27 million in the second close of a venture round, bringing the round's total to $60 million. The round's series was not disclosed. The company...
01:25 , May 6, 2017 |  BioCentury  |  Finance

Next in line

WuXi NextCODE Genomics Inc. could be the final New WuXi Life Science Ltd. subsidiary to head for an IPO. NextCODE, one of three New WuXi subsidiaries, announced May 1 that it raised $75 million in...
16:08 , May 4, 2017 |  BC Week In Review  |  Financial News

WuXi NextCode raises $75M in series B

On May 1, genomics company WuXi NextCode (Cambridge, Mass.) raised $75 million in a series B round led by Temasek and Yunfeng Capital. Amgen Ventures and 3W Partners also participated. WuXi NextCode , Cambridge, Mass. ...